Ładuje się......
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors
BACKGROUND: People with hemophilia A or B with inhibitors are at high risk of bleeding complications. Infusion of bypassing agents, such as recombinant activated FVII (rFVIIa) and plasma‐derived activated prothrombin complex concentrate, are suggested as alternative therapies to factor VIII (haemoph...
Zapisane w:
| Wydane w: | Cochrane Database Syst Rev |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley & Sons, Ltd
2017
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483761/ https://ncbi.nlm.nih.gov/pubmed/28944952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011441.pub2 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|